Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Chronic Low Back Pain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Large-scale testing (Phase 3)Study completedNCT01789970
What this trial is testing

Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain

Who this might be right for
Low Back Pain
Teva Branded Pharmaceutical Products R&D, Inc. 625
Early research (Phase 1)Looking for participantsNCT07122453
What this trial is testing

Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain

Who this might be right for
Lower Back Pain
Centrexion Therapeutics 16
Large-scale testing (Phase 3)Study completedNCT00490919
What this trial is testing

Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain

Who this might be right for
Low Back Pain
Purdue Pharma LP 539
Large-scale testing (Phase 3)Study completedNCT01922739
What this trial is testing

Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets

Who this might be right for
Low Back Pain
Teva Branded Pharmaceutical Products R&D, Inc. 182
Large-scale testing (Phase 3)Study completedNCT01081912
What this trial is testing

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Who this might be right for
Back Pain Lower Back Chronic
Zogenix, Inc. 510
Large-scale testing (Phase 3)Ended earlyNCT00313014
What this trial is testing

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain

Who this might be right for
Back Pain Lower Back Chronic
Purdue Pharma LP 660
Large-scale testing (Phase 3)Study completedNCT00594516
What this trial is testing

Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back Pain

Who this might be right for
Low Back Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 117
Testing effectiveness (Phase 2)Ended earlyNCT00973024
What this trial is testing

A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain

Who this might be right for
Low Back PainLow Back Pain, Recurrent
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 389
Large-scale testing (Phase 3)Study completedNCT01427283
What this trial is testing

Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Who this might be right for
Low Back Pain
Purdue Pharma LP 450
Large-scale testing (Phase 3)Study completedNCT02946073
What this trial is testing

Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain

Who this might be right for
Chronic Lower Back PainChronic Pain
Braeburn Pharmaceuticals 1,053
Large-scale testing (Phase 3)Study completedNCT02362672
What this trial is testing

Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain

Who this might be right for
Low Back PainChronic Pain
Nektar Therapeutics 1,189
Large-scale testing (Phase 3)Study completedNCT02367820
What this trial is testing

Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain

Who this might be right for
Low Back PainChronic Pain
Nektar Therapeutics 638
Large-scale testing (Phase 3)Study completedNCT00487435
What this trial is testing

An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain

Who this might be right for
PainOsteoarthritisLow Back Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,166
Large-scale testing (Phase 3)Study completedNCT00761150
What this trial is testing

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Who this might be right for
Chronic Low Back Pain
AbbVie (prior sponsor, Abbott) 308
Large-scale testing (Phase 3)Study completedNCT00449176
What this trial is testing

Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain

Who this might be right for
Low Back Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 981
Post-approval studies (Phase 4)Study completedNCT00784810
What this trial is testing

Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

Who this might be right for
OsteoarthritisBack Pain
Napp Pharmaceuticals Limited 247
Large-scale testing (Phase 3)WithdrawnNCT01431742
What this trial is testing

Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Low Back Pain

Who this might be right for
PainLow Back Pain
BioDelivery Sciences International
Large-scale testing (Phase 3)Active Not RecruitingNCT06325566
What this trial is testing

Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

Who this might be right for
Degenerative Disc Disease
Mesoblast, Ltd. 300